India ready to produce over five billion COVID vaccine doses by end of 2022: PM Modi
Prime Minister Modi expressed satisfaction over the G20's decision to come up with a 15 per minimum corporate tax to make the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Biotech
Review of Covaxin underway, expect a recommendation within 24 hours: WHO
The Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new…
India committed to supplying COVID-19 vaccines to other nations by year end
The country had suspended exports of COVID-19 vaccines in April to focus on inoculating its own population following a sudden…
WHO Chief discusses Covaxin and resumption of AstraZeneca vaccine supply to COVAX facility with…
COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating timely, equitable and affordable access of…
India resumes vaccine exports as domestic stocks build up: Officials
So far, about four million shots have been exported
Bharat Biotech awaits regulatory approvals to launch Covaxin for children
The SEC on COVID-19 examined the data and deliberated on the EUA application yesterday
Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO
As part of the phase-II/III trial, the two-dose Covaxin was administered with 28 days apart.
Raising GMP standards for vaccines
India has huge vaccine manufacturiing capabilities but ensuring strict adherence to Good Manufacturing Practices (GMP) will be…
Bharat Biotech scouts international COVID-19 vaccine partners
Covaxin, the company's home-grown COVID-19 vaccine approved for emergency use in India, is one of two shots driving the country's…
IVI and Bharat Biotech launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica
IVI is advancing clinical development of BBV87 through a phase-II/III randomised, controlled trial to evaluate the safety and…